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Abstract
Non-coding RNAs (ncRNAs) are an essential class of molecular species that have been difficult to monitor on high
throughput platforms due to frequent lack of polyadenylation. Using a polyadenylation-neutral amplification protocol and
next-generation sequencing, we explore ncRNA expression in eleven human tissues. ncRNAs 7SL, U2, 7SK, and HBII-52 are
expressed at levels far exceeding mRNAs. C/D and H/ACA box snoRNAs are associated with rRNA methylation and
pseudouridylation, respectively: spleen expresses both, hypothalamus expresses mainly C/D box snoRNAs, and testes show
enriched expression of both H/ACA box snoRNAs and RNA telomerase TERC. Within the snoRNA 14q cluster, 14q(I-6) is
expressed at much higher levels than other cluster members. More reads align to mitochondrial than nuclear tRNAs. Many
lincRNAs are actively transcribed, particularly those overlapping known ncRNAs. Within the Prader-Willi syndrome loci, the
snoRNA HBII-85 (group I) cluster is highly expressed in hypothalamus, greater than in other tissues and greater than group II
or III. Additionally, within the disease locus we find novel transcription across a 400,000 nt span in ovaries. This genome-
wide polyA-neutral expression compendium demonstrates the richness of ncRNA expression, their high expression patterns,
their function-specific expression patterns, and is publicly available.
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Introduction
Non-coding RNAs (ncRNAs) are a class of molecular species
that, for example, play regulatory roles, have been implicated in
human diseases, and are essential for stem cells [1,2,3,4,5].
ncRNAs are frequently monitored using qPCR and northern
assays (e.g., [6,7]). While successful, neither is typically run as a
genome-wide high-throughput platform. High throughput micro-
array and next-generation sequencing platforms commonly
employ RNA amplification protocols with either oligo-dT
amplification or random priming of polyA+ purified RNA, with
the intended goal of amplifying polyadenylated mRNA transcripts
(e.g., [8]). As the majority of ncRNA transcripts are not
polyadenylated, ncRNAs transcripts are ineffectively amplified
and thus not monitored by these platforms.
Results and Discussion
To examine ncRNAs in human samples, we amplified eleven
tissue pools using a novel amplification protocol that effectively
amplifies non-ribosomal RNA molecules with lengths greater than
50 nucleotides (nt), including both polyadenylated and non-
polyadenylated transcripts, that additionally preserves the strand
of the RNA molecules [9]. We generated an average of 50 million
sequence reads per tissue, deposited at EMBL (ENA ERP000257;
ArrayExpress E-MTAB-305), and aligned reads to the human
genome using the program BWA [10]. The percentage of
sequence reads aligning to the genome varied from 79% to 90%
per tissue (Table S1).
We first measured the expression of protein-coding mRNAs by
counting and normalizing the reads overlapping each transcript,
generating measurements, for each transcript in each tissue, of the
number overlapped reads per 1000 nt of RNA transcript length
per million alignable reads (RPKM [11]), along with a normalized
uncertainty derived using Poisson statistics [12]. In this compen-
dium (Table S2), we find highly tissue-enriched genes, such as
PRM2 (protamine 2) with 151 RPKM in testes and, amazingly,
zero RPKM in all other tissues. The non-polyadenylated histone
HIST1H2BA has 1,338 RPKM in testes and less than two in other
tissues, demonstrating not only the high tissue-enrichment of this
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transcripts.
Given the ability to monitor polyA- transcripts, we examined
the expression of snoRNAs, scaRNAs, scRNAs, and miscellaneous
ncRNAs. Many ncRNAs are duplicated throughout the genome;
for example, there are hundreds of 7SK-associated transcripts.
Grouping similar transcripts into single ncRNA clusters, such as all
the 7SK and 7SK-related loci, we identified 336 ncRNA clusters
(Supplementary files contain genomic coordinates). For each
cluster, we counted the number of unique reads that map to any of
the associated genomic locations and normalized the counts and
uncertainties to generate RPKM values and error estimates. We
find that 2.9% (in hypothalamus) to 1.1% (in heart) of the aligned
reads map to one of these 336 ncRNA clusters.
Figure 1 shows the 20 clusters with highest RPKM values and
Table S3 lists expression of all ncRNA clusters in each tissue. The
four with highest average RPKM are signal recognition particle
scRNA 7SL (at an incredible 70,000 RPKM in hypothalamus),
spliceosomal snRNA U2 (40,000 RPKM in lung), snRNA 7SK
(15,000 RPKM in hypothalamus), and snoRNA HBII-276 (17,000
RPKM in spleen). In hypothalamus, 104,744 reads align to the
snoRNA HBII-52 cluster, 0.4% of all aligned reads, representing
an amazing 49,000 RPKM. For comparison, the five mRNAs in
hypothalamus with highest RPKM are TTR (transthyretin; 3,300
RPKM), STMN1 (stathmin 1; 1,000 RPKM), MBP (myelin basic
protein; 910 RPKM), HSPA8 (heat shock 70 kDa protein 8; 700
RPKM), and GFAP (glial fibrillary acidic protein; 600 RPKM). In
hypothalamus, the snoRNA HBII-52 cluster shows RPKM 15
times higher than the highest mRNA.
Other examples include HY3 RNA (Ro-associated Y3), which is
expressed at over 1,000 RPKM in all tissues and over 6,000 in
hypothalamus (Figure 2). This expression correlates well with our
qPCR validation, and we find HY3 has much higher overall
RPKM than HY1, HY4, and HY5, as per [13]. BC200
(BCYRN1) is highly enriched in hypothalamus [14], snoRNA
snR39B is enriched in spleen (Figure 2), and tumor suppressor
H19 is enriched in skeletal muscle [15] (Figure S1).
Functionally, snoRNAs can be divided into C/D box and H/
ACA box based on sequence and structure, and are associated
with methylation and pseudouridylation, respectively [16]. As
examples, HBII-438 (C/D box) has 107 RPKM in hypothalamus
and 25 in testes while HBI-6 (H/ACA) is at 166 in testes and 13 in
hypothalamus (Figure S1). 47 H/ACA box snoRNAs have
expression above 10 RPKM: 18 have highest RPKM in testes,
11 in spleen, and two in hypothalamus. Conversely, of the 99 C/D
box snoRNAs with expression above 10 RPKM, 38 are highest in
spleen, 15 in hypothalamus, but none in testes.
Thus, we observe a major shift from C/D box snoRNAs
(methylation) in brain to H/ACA box snoRNAs (pseudouridyla-
tion) in testes. H/ACA box snoRNAs specify uridines for
pseudouridylation, including targets in the ribosome and splice-
osome [17], and mutations impacting pseudouridylation slow
translation and growth rates [18], suggesting a role for
pseudouridine in cellular proliferation, ribosome biogenesis, and
Figure 1. ncRNA expression. Expression (RPKM units) of the 20 monitored ncRNA with highest mean values across eleven tissues.
doi:10.1371/journal.pone.0011779.g001
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telomerase, also encodes an H/ACA box and is implicated in
dyskeratosis congenital [4]. It is a limiting component of
telomerase, and thus essential for tumor, germ, and stem/
progenitor cell proliferation [17,19,20,21]. Indeed, induced
pluripotent stem cells upregulate TERC to restore telomere
elongation[5]. Our data show that TERC is clearly enriched in
testes (Figure 2). Together, the higher expression in testes of
TERC and H/ACA box snoRNAs suggests that these factors are
essential for germ cell proliferation and maintenance.
The sequencing data also enable investigation into snoRNA
gene clusters: the 14q, HBII-85, and HBII-52 snoRNA clusters are
all groups of adjacently located snoRNAs. While they fall within
imprinted regions and have been implicated in disease [22],
measuring expression of individual snoRNAs within each cluster
has nevertheless been complicated by intra-cluster sequence
similarity[23].
On chromosome 14, the 41 member 14q snoRNA cluster can
be broken into three sub-groups: 14q(0), 1 member; 14q(I), 9
members; and 14q(II), 31 members [24] (Figure 3). Despite the
sequence similarity of snoRNAs, the sequencing reads can
discriminate individual members (Table S4) and thus enable
determination of expression of individual members. 14q(I-6) shows
by far the highest expression, at 2,545 RPKM in hypothalamus
(Figure 3). 14q(II-14), 14q(II-12), 14q(II-1) are expressed at highest
levels in hypothalamus at 19, 14, and 13 RPKM, respectively, and
14q(0) is highest in ovaries, at 13 RPKM. Thus, from the 14q
cluster, 14q(I-6) is specifically expressed at significantly higher
levels than all other members.
Clusters HBII-85 and HBII-52 fall within the Prader-Willi
syndrome (PWS) and Angelman syndrome locus on chromosome
15 [22] (Figure 4). For the HBII-85 29 member cluster, sequencing
and qPCR show highest expression in hypothalamus, followed by
kidney, as per [6], and expression above 900 RPKM in all tissues.
Based on sequence similarity, members of the HBII-85 cluster can
be divided into group I (9 members), group II (15 members), and
group III (5 members). While sequence reads can map to multiple
members within a cluster, they do not align across groups (Table
S5). Thus for HBII-85 the cluster, we are able to determine group-
specific RPKM values by counting the number of unique sequence
reads that align only to any member of an individual group. In
hypothalamus, we find group I at 14,439 RPKM, group II at 635,
and group III at 242. Consequently, HBII-85 is expressed at
significant levels in all tissues examined, HBII-85 is enriched in
hypothalamus, and HBII-85 group I expression is significantly
higher than group II or III. Thus, while the HBII-85 cluster is
frequently referred to as a brain-specific snoRNA, we find, as per
original studies of Cavaille et al., [6,24], that it is expressed in all
human tissues examined, albeit at much higher levels in brain.
Finally, the sequence similarity among the 42-member HBII-52
cluster is high enough that sequence reads can align to multiple
members, prohibiting determination of individual expression
(Table S6). Instead of attempting to monitor individual members,
we thus counted the number of unique reads that align to any
cluster member. The sequencing and qPCR data show HBII-52
expression in every tissue, ranging from 12 RPKM in adipose to
an outstanding 49,278 RPKM in hypothalamus (Figure 4). The
high HBII-52 brain enrichment also agrees with northern blots
Figure 2. Individual ncRNA expression. A: HY3 sequencing (RPKM)
and qPCR expression. qPCR values are normalized to 18S and the mean
sequencing value. B, C, and D: expression of BC200, snR39B, and TERC
(telomerase RNA component).
doi:10.1371/journal.pone.0011779.g002
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northern blots in their studies suggest higher HBII-85 than HBII-
52 levels in muscle whereas the sequencing data suggest the
opposite. This may be due to differences in assays, northerns
versus sequencing, the tissue type (skeletal muscle was examined
here), or biological variation.
The sequencing of polyA-neutral RNA enables a less biased
transcriptional exploration of the genome. We have seen that
within the chromosome 15 PWS locus, snoRNA clusters HBII-85
and HBII-52 are expressed at extremely high RPKM. Within the
locus, most genes are highest in hypothalamus, including
snoRNAs HBII-13 (12 RPKM in hypothalamus), HBII-436 (35
RPKM), HBII-437 (34 RPKM), and HBII-438 (107 RPKM), and
mRNAs NDN (33 RPKM) and UBE3A (9 RPKM). Furthermore,
between genes NDN and HBII-436, transcription occurs contin-
uously across a 400,000 kb span from 22.0-22.4 Mb (Figure 5).
Figure 3. Expression of the 14q snoRNA cluster. A: genomic layout of the 41 members of the 14q snoRNA cluster (upper) and maximum RPKM
values for each member, across all tissues (lower). Every second snoRNA is labeled. Y-axis is log10 scale. B: expression of the highly expressed 14q(I-6)
snoRNA. qPCR values are normalized to 18S and the mean sequencing value. Y-axis is linear scale.
doi:10.1371/journal.pone.0011779.g003
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reads per million aligned reads. Testes show 166 reads per million
aligned reads. Conversely, other tissues show significantly lower
expression, such as 11 reads per million aligned in skeletal muscle.
Thus, this identifies a novel, broad span of transcription that falls
within a disease locus that is enriched in ovaries and testes.
The amplification protocol does not effectively amplify RNAs
less than 50 nt length, such as mature miRNAs, and specifically
avoids amplification of long rRNAs 28S, 18S, 16S, and 12S [9].
Nevertheless, reads do align to rRNA 5.8S and 5S (Figure S2) and
we find both expressed in all tissues and enrichment in the lung
sample. The data also shed light on the signal recognition particle
(SRP) ribonucleoprotein protein-RNA complex, including ncRNA
7SL and several protein-coding genes. Across the 11 samples, 7SL
is universally highly expressed (above), SRP mRNAs are expressed
at less than 100 RPKM, and, among SRP mRNAs, SRP9 is
expressed at highest levels in each tissue and highest in
hypothalamus (Figure S3, Table S2).
tRNAs are yet another molecular species that can be detected
(Table S7), and the sequencing data allow a more absolute
measure, expanding on previous ratio measurements [25]. More
reads align to mitochondrial than nuclear tRNAs, averaging over
400 RPKM versus 36 across all tissues and tRNAs, respectively.
However, more reads align to nuclear glycine tRNAs than
mitochondrial glycine tRNAs. Among nuclear glycine tRNAs,
the tRNA recognizing the GGG codon (tRNA-Gly-CCC) is more
abundant than tRNA-Gly-GCC and tRNA-Gly-TCC, which is
different from the codon usage showing GCC is the most
commonly used codon for glycine [26].
Large intergenic noncoding RNAs (lincRNAs) are large
genomic spans of mammalian-conserved sequence that contain
chromatin structure associated with transcription but lacking
known protein-coding genes [27]. Using the previously defined
lincRNA coordinates [27], we find that the sequence reads here
support transcription in many lincRNAs (Table S8). Many reads
overlap lincRNAs that contain rRNA transcripts, such as the 28S
rRNA element in lincRNA chr11:84867425-84942100. Many
reads map to lincRNAs that overlap ncRNAs, such as lincRNA
chr20:36470500-36515575 which overlaps ncRNAs ACA60,
U71a, U71b, U71c, and U71d. Transcription is active in
lincRNA chr11:64946775-64971250, containing the ncRNA
NEAT1 (nuclear paraspeckle assembly transcript 1) [28,29]
which is expressed at 350 RPKM in lung. Similarly, lincRNA
chr11:65022925-65031750 overlaps many reads, most of which
are associated with the ncRNA MALAT1 (metastasis associated
lung adenocarcinoma transcript 1) [8,30] which is expressed
at over 2,000 RPKM in both kidney and lung. lincRNA
chrX:72949400-72989313 contains ncRNAs XIST[31] and
TSIX [32] and shows highest expression in ovaries; chr1:
172098475-172103825 contains ncRNA GAS5, associated with
growth arrest and the glucocorticoid receptor [33], and C/D
box snoRNAs U44, U47, and U74-81 and also shows highest
expression in ovaries. Thus, these sequencing data corroborate
transcription in many lincRNAs, particularly in those contain-
ing known rRNAs and ncRNAs, and provides additional tissue
profiles.
In summary, through high-throughput sequencing of a polyA-
neutral library, we were able to assemble a genome-wide RNA
expression compendium. Rather than acting as housekeeping
genes with uniform and ubiquitous expression, ncRNAs have
distinctive, tissue-specific, expression patterns. Some ncRNAs are
expressed at levels far exceeding mRNA expression. There are
novel, broad regions of rumbling transcription that show tissue-
variable expression.
Materials and Methods
Tissues
We purchased total RNA from Ambion (Austin, USA). Each
tissue samples was pooled from multiple donors. Libraries were
prepared as per Armour et al, 2009[9].
Sequencing
We generated an average of 50 million sequence reads per tissue
using an Illumina GA-II sequencer, with sequence lengths of 36 nt
(adipose, hypothalamus, liver) and 50 nt (colon, heart, kidney,
lung, ovary, skeletal muscle, spleen, testes), deposited at EMBL
(ENA ERP000257; ArrayExpress E-MTAB-305). We trimmed
reads to a common length of 28 nt to avoid aligning sequenced
amplification primers.
Expression profiling
For mRNAs, we downloaded RefSeq transcript coordinates and
associated gene symbols from the UCSC genome browser [34],
assembly hg18. Using only reads mapping to a single gene, we
counted the reads overlapping each transcript in the correct
genomic orientation. We modeled the uncertainty of each
measurement (error) using Poisson statistics, assigning the square
root of the counts as the uncertainty of each measurement [12].
To compare across tissues and transcripts, we normalized both the
counts and uncertainties by the number of alignable reads in each
tissue and by the transcript length, and similarly normalized the
associated normalized uncertainty [11].
For ncRNAs, ncRNA genomic coordinates were downloaded
from the two tracks in the UCSC genome browser[34], assembly
hg18, tracks RNA Genes [35] and sno/miRNAs [23]. For this
analysis, we removed pseudogenes, miRNAs, tRNAs, and rRNAs.
We combined genes labeled as ‘‘related’’, such as 7SK and 7SK-
related, into a single cluster while preserving all genomic locations.
Preference was given to annotation in the RNA Genes file.
Coordinates and names can be found in Supplementary File
XXX. For each ncRNA cluster, we counted the number of unique
reads that mapped to any of the associated genomic locations and
normalized counts and uncertainties to generate RPKM values
and error estimates.
qPCR
Tissue-specific values were normalized to the level of 18S
rRNA. Errors are the standard deviations from triplicate
measurements. To compare to sequencing RPKM values, the
mean for each qPCR was normalized to the corresponding
RPKM mean.
Supporting Information
Figure S1 Expression (RPKM) of H19, HBII-438, and HBI-6.
Found at: doi:10.1371/journal.pone.0011779.s001 (0.12 MB PPT)
Figure S2 Expression (RPKM) of 5.8S and 5S rRNA.
Found at: doi:10.1371/journal.pone.0011779.s002 (0.09 MB PPT)
Figure 4. Expression of the HBII-52 and HBII-85 snoRNA clusters. A: genomic layout of the HBII-52 and HBII-85 snoRNA clusters. B, C, and D:
expression of the HBII-85 group I, II, and III clusters. E: expression of the HBII-52 cluster. F: expression of HBII-85 group I, II, and III in hypothalamus.
doi:10.1371/journal.pone.0011779.g004
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PLoS ONE | www.plosone.org 7 July 2010 | Volume 5 | Issue 7 | e11779Figure S3 Expression (RPKM) of the signal recognition particle
(SRP) ribonucleoprotein protein-RNA complex, including 7SL
(top) and the protein coding components (bottom).
Found at: doi:10.1371/journal.pone.0011779.s003 (0.14 MB PPT)
Table S1 Number of reads and number aligned.
Found at: doi:10.1371/journal.pone.0011779.s004 (0.02 MB
XLS)
Table S2 Expression of RefSeq transcripts.
Found at: doi:10.1371/journal.pone.0011779.s005 (1.28 MB
PDF)
Table S3 Expression of 336 ncRNAs.
Found at: doi:10.1371/journal.pone.0011779.s006 (0.11 MB
PDF)
Table S4 Similarity among 14q cluster snoRNAs, based on the
number of identical 28 nt sequences.
Found at: doi:10.1371/journal.pone.0011779.s007 (0.09 MB
DOC)
Table S5 Similarity among HBII-85 cluster snoRNAs, based on
the number of identical 28 nt sequences.
Found at: doi:10.1371/journal.pone.0011779.s008 (0.09 MB
DOC)
Table S6 Similarity among HBII-52 cluster snoRNAs, based on
the number of identical 28 nt sequences.
Found at: doi:10.1371/journal.pone.0011779.s009 (0.14 MB
DOC)
Table S7 Reads per million aligned per 1000 nt (RPKM)
overlapped by each tRNA.
Found at: doi:10.1371/journal.pone.0011779.s010 (0.04 MB
XLS)
Table S8 Reads per million aligned overlapped by each
lincRNA.
Found at: doi:10.1371/journal.pone.0011779.s011 (0.15 MB
PDF)
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